News
Asianet Newsable on MSN1h
Here’s Why Glenmark Pharma Shares Are Falling Today
The drug maker’s bottom line was dragged down by a ₹3,200 crore litigation charge. Management expects double-digit growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback